Impact of maintenance immunosuppression regimen on anti-SARS-CoV-2 antibody and cellular kinetics in kidney transplant recipients receiving ChAdOx1 as primary vaccination
AZA provided a transient early advantage in immunity responses against SARS-CoV-2, but long-term humoral and cellular kinetics were comparable. Booster doses are essential for sustaining immunity in KTRs, emphasizing the need for tailored vaccination strategies. These findings may inform clinical decisions during pandemics.
Authors
- Hélio O. Tedesco-Silva
- José Medina Pestana
- Julia Soares Reis
- Lúcio Requião-Moura
- Roberto Matias Souza
- Renato Demarchi Foresto
Institutions
- Hospital do Rim e Hipertensão (BR)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- The Brazilian Journal of Infectious Diseases
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1016/j.bjid.2025.104604
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00